Wolters Kluwer Successfully Prices €500 Million 10-Year Eurobond
March 14, 2017 - Wolters Kluwer, a global leader in professional information services, announced today that it has successfully launched and priced a new €500 million 10-year Eurobond. The bonds were sold at an issue price of 99.659 per cent and carry an annual coupon of 1.500 per cent. The settlement date has been set at March 22, 2017. The securities were placed with a broad range of institutional investors across Europe.
The senior unsecured bonds will mature on March 22, 2027. The net proceeds of the offering will be used to refinance existing debt and for general corporate purposes.
Barclays, Commerzbank, NatWest Markets, and Rabobank acted as joint lead managers. The bonds will be listed on the Official List of the Luxembourg Stock Exchange.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in professional information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our solutions and organization, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
| Media | Investors/Analysts | |
| Annemarije Pikaar | Meg Geldens | |
| Corporate Communications | Investor Relations | |
| t + 31 172 641 470 | t + 31 172 641 407 | |
| [email protected] | [email protected] |
Forward-looking Statements
This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/947d2518-1b38-4146-bdfb-b035092858c5


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
U.S. Airline Flight Cancellations Surge After Venezuela Military Operation and FAA Airspace Closures
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Reddit Emerges as a Major Winner in the Shift to AI-Powered Search
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook 



